3.0.0 641 2025-05-14T15:10:53Z 2025-05-14T15:10:53Z Senate S S 2025-02-19 119 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2025-02-19T23:54:59Z 2025-02-19 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2025-02-19 Introduced in Senate IntroReferral 10000 9 Library of Congress K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN N G000386 Sen. Grassley, Chuck [R-IA] Chuck Grassley R IA 2025-02-19 True B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI 2025-02-19 True K000383 Sen. King, Angus S., Jr. [I-ME] Angus King I ME S. 2025-02-19 True M001176 Sen. Merkley, Jeff [D-OR] Jeff Merkley D OR 2025-02-19 True S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH 2025-02-19 True W000802 Sen. Whitehouse, Sheldon [D-RI] Sheldon Whitehouse D RI 2025-02-19 True W000800 Sen. Welch, Peter [D-VT] Peter Welch D VT 2025-02-19 True Health Health 2025-03-17T15:06:45Z

00 2025-02-19 Introduced in Senate 2025-05-14T15:08:01Z <p><strong>Safe and Affordable Drugs from Canada Act of 2025</strong></p><p>This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.</p><p>Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.</p><p>An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs.</p><p>The FDA must publish a list of approved Canadian pharmacies on its website.</p>

Display Title 45 2025-03-14T03:23:18Z Short Title(s) as Introduced 101 2025-03-14T03:23:18Z Introduced in Senate IS Official Title as Introduced 6 2025-03-14T03:18:24Z Introduced in Senate IS Introduced in Senate 2025-02-19T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-119s641is/xml/BILLS-119s641is.xml 2025-02-19 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.